HM Payson & Co’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.23M Sell
15,730
-525
-3% -$42.4K 0.02% 212
2026
Q1
$1.41M Sell
16,255
-359
-2% -$34.4K 0.02% 194
2025
Q4
$1.6M Buy
16,614
+1,889
+13% +$183K 0.02% 175
2025
Q3
$1.4M Sell
14,725
-162
-1% -$14.9K 0.02% 179
2025
Q2
$1.3M Buy
14,887
+365
+3% +$31K 0.02% 182
2025
Q1
$1.3M Buy
14,522
+1,177
+9% +$105K 0.02% 187
2024
Q4
$1.07M Sell
13,345
-1,355
-9% -$117K 0.02% 206
2024
Q3
$1.32M Sell
14,700
-5,769
-28% -$485K 0.02% 192
2024
Q2
$1.61M Sell
20,469
-8,851
-30% -$726K 0.03% 165
2024
Q1
$2.56M Buy
29,320
+8,893
+44% +$759K 0.05% 141
2023
Q4
$1.68M Sell
20,427
-10,828
-35% -$825K 0.03% 159
2023
Q3
$2.45M Buy
31,255
+329
+1% +$27.5K 0.06% 140
2023
Q2
$2.72M Sell
30,926
-3,742
-11% -$322K 0.06% 128
2023
Q1
$2.79M Sell
34,668
-996
-3% -$81.2K 0.07% 121
2022
Q4
$2.77M Sell
35,664
-9,904
-22% -$803K 0.07% 121
2022
Q3
$3.68M Sell
45,568
-4,536
-9% -$408K 0.1% 113
2022
Q2
$4.5M Sell
50,104
-1,336
-3% -$135K 0.12% 101
2022
Q1
$5.71M Sell
51,440
-8,461
-14% -$894K 0.13% 96
2021
Q4
$6.2M Sell
59,901
-3,729
-6% -$432K 0.13% 98
2021
Q3
$7.98M Sell
63,630
-1,802
-3% -$233K 0.19% 83
2021
Q2
$8.12M Sell
65,432
-3,192
-5% -$401K 0.2% 83
2021
Q1
$8.11M Sell
68,624
-3,037
-4% -$356K 0.22% 82
2020
Q4
$8.39M Sell
71,661
-9,826
-12% -$1.08M 0.23% 80
2020
Q3
$8.47M Sell
81,487
-194,075
-70% -$19.5M 0.26% 75
2020
Q2
$25.3M Buy
275,562
+19,817
+8% +$1.9M 0.85% 37
2020
Q1
$23.1M Buy
255,745
+5,290
+2% +$563K 0.91% 37
2019
Q4
$28.4M Buy
250,455
+20,375
+9% +$2.24M 0.91% 40
2019
Q3
$25M Buy
230,080
+7,589
+3% +$792K 0.88% 43
2019
Q2
$21.7M Sell
222,491
-7,628
-3% -$696K 0.78% 46
2019
Q1
$21M Buy
230,119
+226,073
+5,588% +$20.2M 0.8% 50
2018
Q4
$368K Buy
+4,046
New +$378K 1.08% 37
2018
Q3
Sell
-11,756
Closed -$1.01M 346
2018
Q2
$1.01M Buy
+11,756
New +$982K 0.04% 181
2018
Q1
Sell
-11,952
Closed -$965K 350
2017
Q4
$965K Buy
+11,952
New +$957K 0.04% 193
2017
Q3
Sell
-11,825
Closed -$1.05M 340
2017
Q2
$1.05M Buy
+11,825
New +$997K 0.05% 179
2017
Q1
Sell
-11,435
Closed -$814K 347
2016
Q4
$814K Sell
11,435
-1,248
-10% -$98K 0.04% 198
2016
Q3
$1.1M Sell
12,683
-39
-0.3% -$3.4K 0.05% 173
2016
Q2
$1.1M Buy
+12,722
New +$1.03M 0.06% 167
2016
Q1
Sell
-15,309
Closed -$1.18M 343
2015
Q4
$1.18M Buy
+15,309
New +$1.15M 0.06% 166
2015
Q3
Sell
-17,683
Closed -$1.31M 306
2015
Q2
$1.31M Sell
17,683
-1,440
-8% -$110K 0.07% 168
2015
Q1
$1.49M Buy
19,123
+1,792
+10% +$136K 0.07% 155
2014
Q4
$1.25M Buy
17,331
+700
+4% +$48.6K 0.06% 162
2014
Q3
$1.03M Sell
16,631
-949
-5% -$60.3K 0.05% 168
2014
Q2
$1.12M Sell
17,580
-400
-2% -$24.3K 0.06% 164
2014
Q1
$1.11M Sell
17,980
-180
-1% -$10.5K 0.06% 159
2013
Q4
$1.04M Sell
18,160
-775
-4% -$43.9K 0.06% 160
2013
Q3
$1.01M Buy
18,935
+438
+2% +$23.6K 0.06% 162
2013
Q2
$952K Buy
+18,497
New +$914K 0.06% 161

Other funds holding MDT

HM Payson & Co's MDT Position: Q2 2026 in Review

HM Payson & Co reduced its Medtronic (MDT) stake by 3.2% in Q2 2026, selling an estimated $42.4K and leaving 15,730 shares worth $1.23M. The position accounts for 0.02% of the portfolio, ranked #212.

HM Payson & Co first reported a position in MDT in Q2 2013 and has held it in 47 quarters since. The position peaked at $28.4M in Q4 2019. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • HM Payson & Co held 15,730 shares of Medtronic worth $1.23M as of Q2 2026.
  • HM Payson & Co sold 525 Medtronic shares in Q2 2026, an estimated $42.4K.
  • Medtronic made up 0.02% of HM Payson & Co's portfolio in Q2 2026, its #212 holding.
  • HM Payson & Co first reported a position in Medtronic in Q2 2013 and has held it in 47 quarters since.
  • HM Payson & Co's Medtronic position peaked at $28.4M in Q4 2019.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.